Wenbin Jiang, President and CEO at Cytek Biosciences, Inc. (CTKB), sold 40,000 shares at $8.88 ($355K) on 2023-04-10, disclosed to the SEC on 2023-04-11.
Scheduled sale ($355k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.88 | 20,000 | $178K | 50.0% |
| 2 | $8.88 | 20,000 | $178K | 50.0% |
| Total | $8.88 avg | 40,000 | $355K | 100% |
| Filing → |
| CTKB | SELL | 2023-09-08 | $137K | — | Filing → |
| CTKB | SELL | 2023-08-08 | $362K | — | Filing → |
| CTKB | SELL | 2023-07-07 | $170K | — | Filing → |